Open Payments

ANGELA KAY FITCH

Type
Physician · Allopathic & Osteopathic Physicians / Internal Medicine
Where
NEEDHAM, MA
NPI
1811945959
Received
$400,693 in 428 records, 2019 to 2025 ($387,243 general, $13,449 research)
As principal investigator
$217,665 of research payments to others in 21 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment175$182,326
2024General payment146$121,937
2024Research payment4$10,988
2023General payment66$58,744
2023Research payment2$2,461
2022General payment22$21,952
2021General payment6$1,947
2019General payment7$335

By company

CompanyRecordsAmountYears
Novo Nordisk Inc183$168,8232019–2025
Lilly USA, LLC157$117,5232023–2025
Currax Pharmaceuticals LLC34$51,1912024–2025
Eli Lilly and Company16$31,3782022–2025
Boehringer Ingelheim Pharmaceuticals, Inc.23$16,8852025
Rhythm Pharmaceuticals, Inc.4$5,6072024–2025
VIVUS LLC2$2,8622022
Novo Nordisk AS1$2,8122023
ABBVIE INC.2$2,5302025
PFIZER INC.1$9002025
SCYNEXIS, Inc.1$922022
Amgen Inc.2$402024–2025
Madrigal Pharmaceuticals1$252024
Abbott Laboratories1$212023

By nature of payment

NatureRecordsAmount
Compensation for services other than consulting, including serving as faculty or as a speaker at a v127$212,073
Consulting Fee44$103,101
Travel and Lodging105$56,229
Research payment6$13,449
Food and Beverage142$11,081
Honoraria4$4,757

Records

DateCompanyAmountNatureFormProductStudyYear
2025-12-22PFIZER INC.$900Consulting FeeCash or cash equivalent2025
2025-12-08Boehringer Ingelheim Pharmaceuticals, Inc.$4,150Consulting FeeCash or cash equivalent2025
2025-12-08Boehringer Ingelheim Pharmaceuticals, Inc.$140Travel and LodgingIn-kind items and services2025
2025-12-08Boehringer Ingelheim Pharmaceuticals, Inc.$35Food and BeverageIn-kind items and services2025
2025-12-01Boehringer Ingelheim Pharmaceuticals, Inc.$1,037Consulting FeeCash or cash equivalent2025
2025-11-24Currax Pharmaceuticals LLC$4,500Consulting FeeCash or cash equivalentCONTRAVE Drug, Obesity2025
2025-11-20Eli Lilly and Company$1,925Consulting FeeCash or cash equivalent2025
2025-11-20Eli Lilly and Company$1,925Consulting FeeCash or cash equivalent2025
2025-11-19Novo Nordisk Inc$1,627Consulting FeeCash or cash equivalent Drug, Multiple Therapeutic Areas2025
2025-11-13Boehringer Ingelheim Pharmaceuticals, Inc.$90Food and BeverageIn-kind items and services2025
2025-11-12Lilly USA, LLC$2,200Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-11-12Lilly USA, LLC$1,925Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-11-10Boehringer Ingelheim Pharmaceuticals, Inc.$307Travel and LodgingIn-kind items and services2025
2025-11-07Currax Pharmaceuticals LLC$1,624Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-11-06Currax Pharmaceuticals LLC$229Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-11-06Currax Pharmaceuticals LLC$133Food and BeverageIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-11-05Boehringer Ingelheim Pharmaceuticals, Inc.$1,660Consulting FeeCash or cash equivalent2025
2025-11-02Currax Pharmaceuticals LLC$230Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-10-28Boehringer Ingelheim Pharmaceuticals, Inc.$398Travel and LodgingIn-kind items and services2025
2025-10-22Lilly USA, LLC$1,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-10-16Lilly USA, LLC$15Food and BeverageIn-kind items and servicesMOUNJARO Drug, Diabetes2025
2025-10-08Novo Nordisk Inc$2,092Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2025
2025-10-08Novo Nordisk Inc$102Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2025
2025-09-12Lilly USA, LLC$2,200Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-09-12Lilly USA, LLC$1,925Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-09-05Currax Pharmaceuticals LLC$1,145Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-09-05Currax Pharmaceuticals LLC$566Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-09-02Boehringer Ingelheim Pharmaceuticals, Inc.$415Consulting FeeCash or cash equivalent2025
2025-08-29Boehringer Ingelheim Pharmaceuticals, Inc.$190Travel and LodgingIn-kind items and services2025
2025-08-28Currax Pharmaceuticals LLC$925HonorariaIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-08-26Lilly USA, LLC$2,200Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-08-26Lilly USA, LLC$1,925Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-08-21Lilly USA, LLC$1,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-08-21Lilly USA, LLC$390Travel and LodgingIn-kind items and services2025
2025-08-21Lilly USA, LLC$314Travel and LodgingIn-kind items and services2025
2025-08-21Lilly USA, LLC$292Travel and LodgingIn-kind items and services2025
2025-08-21Lilly USA, LLC$115Food and BeverageCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-08-13Currax Pharmaceuticals LLC$4,800Consulting FeeCash or cash equivalentCONTRAVE Drug, Obesity2025
2025-08-12Boehringer Ingelheim Pharmaceuticals, Inc.$7,055Consulting FeeCash or cash equivalent2025
2025-08-12Boehringer Ingelheim Pharmaceuticals, Inc.$140Travel and LodgingIn-kind items and services2025
2025-08-12Boehringer Ingelheim Pharmaceuticals, Inc.$35Food and BeverageIn-kind items and services2025
2025-08-11Novo Nordisk Inc$6,161Consulting FeeCash or cash equivalentOzempic Drug, Diabetes2025
2025-08-11Novo Nordisk Inc$963Travel and LodgingIn-kind items and servicesOzempic Drug, Diabetes2025
2025-08-11Novo Nordisk Inc$453Travel and LodgingIn-kind items and servicesOzempic Drug, Diabetes2025
2025-08-11Novo Nordisk Inc$281Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2025
2025-08-11Novo Nordisk Inc$216Travel and LodgingIn-kind items and servicesOzempic Drug, Diabetes2025
2025-08-11Novo Nordisk Inc$18Food and BeverageIn-kind items and services2025
2025-08-06Lilly USA, LLC$2,200Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-08-06Lilly USA, LLC$1,925Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-08-04Lilly USA, LLC$449Travel and LodgingIn-kind items and services2025
2025-08-01Currax Pharmaceuticals LLC$464Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-08-01Currax Pharmaceuticals LLC$59Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-08-01Currax Pharmaceuticals LLC$13Food and BeverageIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-07-30Rhythm Pharmaceuticals, Inc.$1,596HonorariaCash or cash equivalent2025
2025-07-30Rhythm Pharmaceuticals, Inc.$1,596Consulting FeeCash or cash equivalent2025
2025-07-19Boehringer Ingelheim Pharmaceuticals, Inc.$29Food and BeverageIn-kind items and services2025
2025-07-17Lilly USA, LLC$2,200Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-07-17Lilly USA, LLC$825Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-07-17Boehringer Ingelheim Pharmaceuticals, Inc.$250Travel and LodgingIn-kind items and services2025
2025-07-17Boehringer Ingelheim Pharmaceuticals, Inc.$142Food and BeverageIn-kind items and services2025
2025-07-17Boehringer Ingelheim Pharmaceuticals, Inc.$59Food and BeverageIn-kind items and services2025
2025-07-17Boehringer Ingelheim Pharmaceuticals, Inc.$54Food and BeverageIn-kind items and services2025
2025-07-17Boehringer Ingelheim Pharmaceuticals, Inc.$49Food and BeverageIn-kind items and services2025
2025-07-17Boehringer Ingelheim Pharmaceuticals, Inc.$17Food and BeverageIn-kind items and services2025
2025-07-17Boehringer Ingelheim Pharmaceuticals, Inc.$13Food and BeverageIn-kind items and services2025
2025-07-15Lilly USA, LLC$88Food and BeverageCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-07-11Boehringer Ingelheim Pharmaceuticals, Inc.$136Food and BeverageIn-kind items and services2025
2025-06-30Boehringer Ingelheim Pharmaceuticals, Inc.$477Travel and LodgingIn-kind items and services2025
2025-06-25Novo Nordisk Inc$930Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-06-25Novo Nordisk Inc$691Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2025
2025-06-22Novo Nordisk Inc$5,463Consulting FeeCash or cash equivalentSaxenda Drug, Obesity2025
2025-06-22Novo Nordisk Inc$2,145Travel and LodgingIn-kind items and servicesSaxenda Drug, Obesity2025
2025-06-22Novo Nordisk Inc$771Travel and LodgingIn-kind items and servicesSaxenda Drug, Obesity2025
2025-06-22Novo Nordisk Inc$380Travel and LodgingIn-kind items and servicesSaxenda Drug, Obesity2025
2025-06-22Novo Nordisk Inc$77Food and BeverageIn-kind items and servicesSaxenda Drug, Obesity2025
2025-06-21Novo Nordisk Inc$40Food and BeverageIn-kind items and services2025
2025-06-21Currax Pharmaceuticals LLC$16Food and BeverageIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-06-17Lilly USA, LLC$1,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-06-10ABBVIE INC.$550Consulting FeeCash or cash equivalent2025
2025-06-05Lilly USA, LLC$2,200Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-06-05Lilly USA, LLC$825Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-05-29Novo Nordisk Inc$92Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2025
2025-05-28Lilly USA, LLC$2,200Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-05-28Lilly USA, LLC$1,925Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-05-22Novo Nordisk Inc$2,092Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2025
2025-05-22Lilly USA, LLC$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-05-22Novo Nordisk Inc$107Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2025
2025-05-21Lilly USA, LLC$888Travel and LodgingIn-kind items and services2025
2025-05-21Lilly USA, LLC$93Food and BeverageCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-05-14Currax Pharmaceuticals LLC$1,138Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-05-11Currax Pharmaceuticals LLC$113Food and BeverageIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-05-08Currax Pharmaceuticals LLC$11,222Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-05-08Currax Pharmaceuticals LLC$4,500Consulting FeeCash or cash equivalentCONTRAVE Drug, Obesity2025
2025-05-06Lilly USA, LLC$1,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-04-30Currax Pharmaceuticals LLC$856HonorariaIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-04-26Amgen Inc.$27Food and BeverageIn-kind items and services2025
2025-04-10Lilly USA, LLC$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-04-08Lilly USA, LLC$1,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-04-07Lilly USA, LLC$1,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-04-01Novo Nordisk Inc$930Consulting FeeCash or cash equivalentSaxenda Drug, Obesity2025
2025-03-27Novo Nordisk Inc$2,673Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2025
2025-03-27Novo Nordisk Inc$752Travel and LodgingIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-27Novo Nordisk Inc$114Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-27Novo Nordisk Inc$23Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-22Novo Nordisk Inc$5,928Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2025
2025-03-22Novo Nordisk Inc$379Travel and LodgingIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-22Novo Nordisk Inc$138Travel and LodgingIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-22Novo Nordisk Inc$124Food and BeverageIn-kind items and services2025
2025-03-22Novo Nordisk Inc$54Food and BeverageIn-kind items and services2025
2025-03-22Novo Nordisk Inc$30Food and BeverageIn-kind items and services2025
2025-03-21Novo Nordisk Inc$4,998Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2025
2025-03-21Novo Nordisk Inc$379Travel and LodgingIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-21Novo Nordisk Inc$350Travel and LodgingIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-21Novo Nordisk Inc$294Travel and LodgingIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-21Novo Nordisk Inc$72Food and BeverageIn-kind items and services2025
2025-03-21Novo Nordisk Inc$42Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-20Novo Nordisk Inc$4,766Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2025
2025-03-20Novo Nordisk Inc$960Travel and LodgingIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-20Novo Nordisk Inc$124Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-17Eli Lilly and Company$2,750Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-03-17Eli Lilly and Company$1,925Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2025
2025-03-17Lilly USA, LLC$1,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-03-13Lilly USA, LLC$2,200Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-03-13Lilly USA, LLC$825Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-03-12Novo Nordisk Inc$22Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-11Eli Lilly and Company$620Travel and LodgingIn-kind items and services2025
2025-03-11Eli Lilly and Company$345Travel and LodgingIn-kind items and services2025
2025-03-11Lilly USA, LLC$135Travel and LodgingIn-kind items and services2025
2025-03-11Lilly USA, LLC$123Travel and LodgingIn-kind items and services2025
2025-03-10Lilly USA, LLC$124Food and BeverageCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-03-08Novo Nordisk Inc$1,860Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2025
2025-03-06Novo Nordisk Inc$4,068Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2025
2025-03-06Novo Nordisk Inc$805Travel and LodgingIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-06Novo Nordisk Inc$77Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2025
2025-03-05Currax Pharmaceuticals LLC$1,500Consulting FeeCash or cash equivalentCONTRAVE Drug, Obesity2025
2025-02-25Currax Pharmaceuticals LLC$145Food and BeverageIn-kind items and servicesCONTRAVE Drug, Obesity2025
2025-02-17Novo Nordisk Inc$2,790Consulting FeeCash or cash equivalentSaxenda Drug, Obesity2025
2025-02-17Novo Nordisk Inc$930Consulting FeeCash or cash equivalentSaxenda Drug, Obesity2025
2025-02-10Lilly USA, LLC$170Travel and LodgingCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-02-10Lilly USA, LLC$108Food and BeverageCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-02-10Lilly USA, LLC$39Food and BeverageCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-02-10Lilly USA, LLC$24Food and BeverageCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-01-31Lilly USA, LLC$1,800Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-01-31Lilly USA, LLC$1,575Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-01-31Lilly USA, LLC$217Travel and LodgingCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-01-31Lilly USA, LLC$175Travel and LodgingIn-kind items and services2025
2025-01-30Lilly USA, LLC$4,500Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-01-28Lilly USA, LLC$241Travel and LodgingIn-kind items and services2025
2025-01-28Lilly USA, LLC$211Travel and LodgingIn-kind items and services2025
2025-01-28Lilly USA, LLC$180Travel and LodgingIn-kind items and services2025
2025-01-23Lilly USA, LLC$2,031Travel and LodgingIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$545Travel and LodgingIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$253Travel and LodgingIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$253Travel and LodgingIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$253Travel and LodgingIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$253Travel and LodgingIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$197Travel and LodgingIn-kind items and services2025
2025-01-23Lilly USA, LLC$121Travel and LodgingIn-kind items and services2025
2025-01-23Lilly USA, LLC$115Food and BeverageIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$70Travel and LodgingIn-kind items and services2025
2025-01-23Lilly USA, LLC$60Food and BeverageIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$55Food and BeverageIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$39Travel and LodgingIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$39Travel and LodgingIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$39Travel and LodgingIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$39Travel and LodgingIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$35Food and BeverageIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$35Food and BeverageIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$25Food and BeverageIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$25Food and BeverageIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$25Food and BeverageIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-23Lilly USA, LLC$10Food and BeverageIn-kind items and servicesZEPBOUND Drug, Obesity2025
2025-01-22Lilly USA, LLC$225Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-01-10ABBVIE INC.$1,980Consulting FeeCash or cash equivalent2025
2025-01-01Novo Nordisk Inc$1,185Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2025
2024-12-10Novo Nordisk Inc$15Travel and LodgingIn-kind items and servicesWegovy Drug, Obesity2024
2024-12-05Novo Nordisk Inc$938Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2024
2024-12-03Novo Nordisk Inc$750Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2024
2024-11-20Currax Pharmaceuticals LLC$2,375Consulting FeeCash or cash equivalentCONTRAVE Drug, Obesity2024
2024-11-18Lilly USA, LLC$1,350Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2024
2024-11-13Currax Pharmaceuticals LLC$3,000Consulting FeeCash or cash equivalentCONTRAVE Drug, Obesity2024
2024-11-08Currax Pharmaceuticals LLC$4,500Consulting FeeCash or cash equivalentCONTRAVE Drug, Obesity2024
2024-11-06Currax Pharmaceuticals LLC$618Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2024
2024-11-06Currax Pharmaceuticals LLC$162Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2024
2024-11-06Madrigal Pharmaceuticals$25Food and BeverageIn-kind items and servicesRESMETIROM Drug, LIVER DISEASE2024
2024-11-05Currax Pharmaceuticals LLC$120Food and BeverageIn-kind items and servicesCONTRAVE Drug, Obesity2024
2024-11-05Amgen Inc.$13Food and BeverageIn-kind items and services2024
2024-11-03Novo Nordisk Inc$105Food and BeverageIn-kind items and services2024
2024-11-02Currax Pharmaceuticals LLC$501Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2024
2024-11-02Currax Pharmaceuticals LLC$189Travel and LodgingIn-kind items and servicesCONTRAVE Drug, Obesity2024
2024-10-16Novo Nordisk Inc$1,687Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2024
2024-10-16Novo Nordisk Inc$103Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2024
2024-10-15Novo Nordisk Inc$143Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2024
2024-10-14Novo Nordisk Inc$24Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2024
2024-10-09Currax Pharmaceuticals LLC$20Food and BeverageIn-kind items and servicesCONTRAVE Drug, Obesity2024
2024-10-03Novo Nordisk Inc$2,437Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2024
2024-10-03Novo Nordisk Inc$102Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2024
2024-10-01Novo Nordisk Inc$1,687Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWegovy Drug, Obesity2024
2024-10-01Novo Nordisk Inc$103Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2024
2024-09-26Eli Lilly and Company$2,250Consulting FeeCash or cash equivalent2024

The latest 200 records of 428.

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2025-03-11Eli Lilly and CompanySEEN MEDICAL OF MA PC DBA KNOWNWELL$8,091A PHASE 2, PARALLEL-GROUP, DOUBLE-BLIND STUDY TO INVESTIGATE WEIGHT MANAGEMENT WITH LY3841136 COMPARED WITH PLACEBO IN A2025
2025-02-04Eli Lilly and CompanySEEN MEDICAL OF MA PC DBA KNOWNWELL$55,718PHASE 2 STUDY WITH COMBINATION OF VEMURAFENIB WITH COBIMETINIB IN B-RAF V600E/K MUTATED MELANOMA PATIENTS TO NORMALIZE L2025
2025-01-31Eli Lilly and CompanyKNOWNWELL$4,222A PHASE 2, PARALLEL-GROUP, DOUBLE-BLIND STUDY TO INVESTIGATE WEIGHT MANAGEMENT WITH LY3549492 ONCE DAILY COMPARED WITH P2025
2025-01-30Eli Lilly and CompanyKNOWNWELL$2,035PHASE 2 STUDY WITH COMBINATION OF VEMURAFENIB WITH COBIMETINIB IN B-RAF V600E/K MUTATED MELANOMA PATIENTS TO NORMALIZE L2025
2025-01-19Eli Lilly and CompanyKNOWNWELL$3,230A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE INTERVENTIONS FOR CHRONIC WEIGHT MANAGEMENT I2025
2025-01-09Eli Lilly and CompanyKNOWNWELL$1,634A PHASE 2, PARALLEL-GROUP, DOUBLE-BLIND STUDY TO INVESTIGATE WEIGHT MANAGEMENT WITH LY3841136 COMPARED WITH PLACEBO IN A2025
2025-01-09Eli Lilly and CompanyKNOWNWELL$888A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE INTERVENTIONS FOR CHRONIC WEIGHT MANAGEMENT I2025
2025-01-09Eli Lilly and CompanyKNOWNWELL$5,975A PHASE 2, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE WEIGHT MANAGEMENT WITH LY3841136 AND TI2025
2025-01-07Eli Lilly and CompanySEEN MEDICAL OF MA PC DBA KNOWNWELL$13,349A PHASE 2, PARALLEL-GROUP, DOUBLE-BLIND STUDY TO INVESTIGATE WEIGHT MANAGEMENT WITH LY3549492 ONCE DAILY COMPARED WITH P2025
2025-01-07Eli Lilly and CompanySEEN MEDICAL OF MA PC DBA KNOWNWELL$27,525A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE INTERVENTIONS FOR CHRONIC WEIGHT MANAGEMENT I2025
2024-10-16Eli Lilly and CompanyKNOWNWELL$513A PHASE 2, PARALLEL-GROUP, DOUBLE-BLIND STUDY TO INVESTIGATE WEIGHT MANAGEMENT WITH LY3549492 ONCE DAILY COMPARED WITH P2024
2024-09-15Eli Lilly and CompanyKNOWNWELL$3,200A PHASE 2, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE WEIGHT MANAGEMENT WITH LY3841136 AND TI2024
2024-08-27Eli Lilly and CompanySEEN MEDICAL OF MA PC DBA KNOWNWELL$45,536PHASE 2 STUDY WITH COMBINATION OF VEMURAFENIB WITH COBIMETINIB IN B-RAF V600E/K MUTATED MELANOMA PATIENTS TO NORMALIZE L2024
2024-08-20Eli Lilly and CompanySEEN MEDICAL OF MA PC DBA KNOWNWELL$15,000A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE INTERVENTIONS FOR CHRONIC WEIGHT MANAGEMENT I2024
2024-08-20Eli Lilly and CompanySEEN MEDICAL OF MA PC DBA KNOWNWELL$22,041A PHASE 2, PARALLEL-GROUP, DOUBLE-BLIND STUDY TO INVESTIGATE WEIGHT MANAGEMENT WITH LY3841136 COMPARED WITH PLACEBO IN A2024
2024-08-08Eli Lilly and CompanyKNOWNWELL$997A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE INTERVENTIONS FOR CHRONIC WEIGHT MANAGEMENT I2024
2024-08-08Eli Lilly and CompanyKNOWNWELL$1,362A PHASE 2, PARALLEL-GROUP, DOUBLE-BLIND STUDY TO INVESTIGATE WEIGHT MANAGEMENT WITH LY3841136 COMPARED WITH PLACEBO IN A2024
2024-07-09Eli Lilly and CompanyKNOWNWELL$4,048PHASE 2 STUDY WITH COMBINATION OF VEMURAFENIB WITH COBIMETINIB IN B-RAF V600E/K MUTATED MELANOMA PATIENTS TO NORMALIZE L2024
2021-03-25Boehringer Ingelheim France S.A.S.Massachusetts General Hospital$1,600Ph IIb dose finding vs placebo in patients with Obesity2021
2021-03-03Boehringer Ingelheim Pharmaceuticals, Inc.Massachusetts General Hospital$520Ph IIb dose finding vs placebo in patients with Ob2021
2021-03-03Boehringer Ingelheim France S.A.S.Massachusetts General Hospital$177Ph IIb dose finding vs placebo in patients with Obesity2021

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Norfolk CountyNeedham CDP

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Needham, MA, county Norfolk County, MA, state Massachusetts; placed by its city name.

MeasurePlace (city or town)
Needham, MA
County
Norfolk County, MA
State
Massachusetts
Population B0100332,459730,0827,044,056
Population, 2020 census P132,091725,9817,029,917
Median age B0100243.140.940.0
Under 18 B0100127.5%20.5%19.4%
65 and over B0100117.7%17.8%17.9%
Households B1100111,586283,3682,785,042
Foreign born B0500216.8%19.3%18.0%
Median household income B19013$214,308$130,739$103,960
Median family income B19113$250,001$170,406$131,675
Per capita income B19301$102,328$71,758$57,897
Poverty rate B170013.7%6.7%10.0%
Unemployment rate B230254.4%4.9%5.2%
Civilian labor force B2302516,759414,6083,911,446
Mean commute (minutes) B0801327.732.529.1
Bachelor's degree or higher B1500381.9%58.8%47.3%
Housing units B2500111,929295,2273,030,406
Owner-occupied B2500383.1%68.7%62.5%
Renters B2500316.9%31.3%37.5%
Median home value B25077$1,188,500$683,900$562,100
Median gross rent B25064$2,409$2,149$1,762
White, not Hispanic B0300280.8%68.7%66.6%
Black B030021.5%7.1%6.4%
Hispanic or Latino B030023.6%5.8%13.3%
Asian B030029.9%12.4%7.3%
American Indian and Alaska Native B030020.0%0.1%0.1%

Economy now FRED unemployment 4.3% in Sep 2026 (4.6% a year earlier); per capita personal income $98,700 in 2025, up 27% in five years (+2.3% after inflation); Unemployment rate: 3.8% in Sep 2016 to 4.3% in Sep 2026; low 3.0%, high 17.8% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Needham, MA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.